Skip to main content
SpringerLink
Log in

Cervical Carcinoma Surveillance Counterpoint: Japan

  • Chapter
  • First Online:
Patient Surveillance After Cancer Treatment

Part of the book series: Current Clinical Oncology ((CCO))

  • 135 Accesses

Abstract

Uterine cervical cancer is one of the most common malignancies affecting women in developing countries, with approximately 500,000 new cases diagnosed annually [1]. Approximately 11,270 new cases and 4,070 deaths are anticipated in the United States for 2009 [2]. In Japan, the cervical cancer incidence has remained stable with 8,832 cases diagnosed in 1975 and 8,779 cases reported in 2002. The number of deaths has increased slightly from 1,583 cases in 1958 to 2,481 cases in 2006 [3]. However, the number of new cases per year in Japan of the other female malignancies has annually increased to 249,643 and the number of deaths per year has increased to 131,262. Therefore, the number of deaths caused by cervical cancer comprises only 1.8 % of the deaths from all kinds of gynecological malignancies. Early detection of cervical cancer and its precursors is quite effective. Until the early 1970s, approximately 75–80 % of cervical cancer cases in the United States were invasive at the time of diagnosis [4]. The national screening system for detecting cervical cancer and its precursors has dramatically reduced the incidence and mortality rate of this malignancy in Japan. Since 2004, biennial cervical cancer screening has been available to all Japanese women over the age of 20. The number of women screened was 3,538,132 in 2007; additional diagnostic testing was needed for 40,392, resulting in the identification of 1,921 cancer cases [5]. However, only 18.8 % of eligible women were screened. Therefore, a significant number of cancers likely will be prevented by increasing the screening rate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med. 1996;334:1030–8.

    Article  PubMed  CAS  Google Scholar 

  2. American Cancer Society. Cancer Facts & Figures-2009. (http://www.cancer.org), Accessed 8 May 2009.

  3. National Cancer Center, Japan. 2009. (http://ganjoho.jp/professional/statistics/statistics.html). Center for Cancer Control and Information Services. Accessed 8 May 2009.

  4. National Cancer Institute. Statistics of cervix uteri cancer. Rockville, MD: National Cancer Institute; 2003.

    Google Scholar 

  5. Japanese Ministry of Health, Labour and Welfare. Health and welfare services for the elderly. The implementation status of health services. (2009) http://www.mhlw.go.jp. Accessed 8 May 2009.

  6. Hacker NF. Cervical cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 345–405.

    Google Scholar 

  7. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991;184:9–13.

    Article  PubMed  CAS  Google Scholar 

  8. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer T, von Knebel Doeberitz M. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene. 2002;21:419–26.

    Article  PubMed  CAS  Google Scholar 

  9. Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, et al. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene. 2002;21:5631–42.

    Article  PubMed  CAS  Google Scholar 

  10. Nishimura M, Furumoto H, Kato T, Kamada M, Aono T. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer. Gynecol Oncol. 2000;79:201–6.

    Article  PubMed  CAS  Google Scholar 

  11. Inoue M, Sakaguchi J, Sasagawa T, Tango M. The evaluation of human papilloma virus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer. 2006;16:1007–13.

    Article  PubMed  CAS  Google Scholar 

  12. Annual report on cervical cancer treatment in 2007. Acta Obst Gynaec Jpn. 2009;61:914–38.

    Google Scholar 

  13. Five-year result of cervical cancer patients who received treatments in 1994. Acta Obst Gynaec Jpn. 2009;61:1042–54.

    Google Scholar 

  14. Burghardt E, Pickel H, Haas J, Lahousen M. Prognostic factors and operative treatment of Stages IB to IIB cervical cancer. Am J Obstet Gynecol. 1987;156:988–96.

    PubMed  CAS  Google Scholar 

  15. Noguchi H, Schiozawa I, Sakai Y, Yamazaki T, Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol. 1987;27:150–8.

    Article  PubMed  CAS  Google Scholar 

  16. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992;69:181–6.

    Article  PubMed  CAS  Google Scholar 

  17. Pickel H, Haas J, Lahousen M. Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 1997;71:209–13.

    Article  PubMed  CAS  Google Scholar 

  18. Stehman FB, Perez CA, Kurman RJ, Thigpen JT. Uterine cervix. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and practice of gynecologic oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 841–918.

    Google Scholar 

  19. van Nagell Jr JR, Rayburn W, Donaldson ES, Hanson M, Gay EC, Yoneda J, Marayuma Y, Powell DF. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer. 1979;44:2354–61.

    Article  PubMed  Google Scholar 

  20. Look KY, Rocereto TF. Relapse patterns in FIGO stage IB carcinoma of the cervix. Gynecol Oncol. 1990;38:114–20.

    Article  PubMed  CAS  Google Scholar 

  21. Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000;78:187–93.

    Article  PubMed  CAS  Google Scholar 

  22. Ansink A, de Barros Lopes A, Naik R, Monaghan JM. Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow-up surveillance. Br J Obstet Gynaecol. 1996;103:1156–8.

    Article  PubMed  CAS  Google Scholar 

  23. Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A. Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand. 2002;81:351–5.

    Article  PubMed  Google Scholar 

  24. Morice P, Deyrolle C, Rey A, Atallah D, Pautier P, Camatte S, et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann Oncol. 2004;15:218–23.

    Article  PubMed  CAS  Google Scholar 

  25. Olaitan A, Murdoch J, Anderson R, James J, Graham J, Barley V. A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int J Gynecol Cancer. 2001;11:349–53.

    Article  PubMed  CAS  Google Scholar 

  26. Choi JI, Kim SH, Seong CK, Sim JS, Lee HJ, Do KH. Recurrent uterine cervical carcinoma: spectrum of imaging findings. Korean J Radiol. 2000;1:198–207.

    Article  PubMed  CAS  Google Scholar 

  27. Jeong YY, Kang HK, Chung TW, Seo JJ, Park JG. Uterine cervical carcinoma after therapy: CT and MR imaging findings. Radiographics. 2003;23:969–81.

    Article  PubMed  Google Scholar 

  28. Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol. 2006;103:165–70.

    Article  PubMed  Google Scholar 

  29. Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, et al. Serum squamous cell carcinoma antigen and CYFTA 21-1 in cervical cancer treatment. Int J Radiat Oncol Biol Phys. 2002;52:23–32.

    Article  PubMed  CAS  Google Scholar 

  30. Bolli JA, Doering DL, Bosscher JR, Day Jr TG, Rao CV, Owens K, et al. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1994;55:169–73.

    Article  PubMed  CAS  Google Scholar 

  31. Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol. 2001;19:3960–6.

    PubMed  CAS  Google Scholar 

  32. Chang Y, Ng TY, Ngan HYS, Wong LC. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost effective? Gynecol Oncol. 2002;84:7–11.

    Article  Google Scholar 

  33. Herzog TJ, Wright JD. The impact of cervical cancer on quality of life-the components and means for management. Gynecol Oncol. 2007;107:572–7.

    Article  PubMed  Google Scholar 

  34. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.

    Article  PubMed  CAS  Google Scholar 

  35. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005;23:7428–36.

    Article  PubMed  Google Scholar 

  36. Shepherd JH, Milliken DA. Conservative surgery for carcinoma of the cervix. Clin Oncol. 2008;20:395–400.

    Article  CAS  Google Scholar 

  37. Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer. 2006;16:380–4.

    Article  PubMed  CAS  Google Scholar 

  38. National Comprehensive Cancer Network 2013. Practice guidelines in oncology cervical cancer version 2. http://www.nccn.org. Accessed on 2 Nov 2012.

  39. Duk JM, De Bruijn HWA, Groenier KH, Fleuren GJ, Aalders JG. Adenocarcinoma of the cervix. Cancer. 1990;65:1830–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan

    Kenzo Sonoda MD, PhD, Hiroaki Kobayashi MD, PhD & Norio Wake MD, PhD

Authors
  1. Kenzo Sonoda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroaki Kobayashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norio Wake MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenzo Sonoda MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Surgery, Saint Louis University, Vista Avenue 3635, St. Louis, 63110-0050, Missouri, USA

    Frank E. Johnson

  2. Fac. Medicine, Dept. Surgery II, Kyushu University, Fukuoka, 812-8582, Japan

    Yoshihiko Maehara

  3. BC Cancer Agency, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    George P. Browman

  4. School of Medicine, Washington University, S. Euclid Ave. 660, St. Louis, 63110, Missouri, USA

    Julie A. Margenthaler

  5. St Helens Teaching Hospital, University of Liverpool, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  6. Sydney Cancer Centre, Sydney Melanoma Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, 2050, New South Wales, Australia

    John F. Thompson

  7. Saint Louis University Medical Center, Saint Louis, 63103, Missouri, USA

    David Y. Johnson

  8. Dana-Farber Cancer Institute, Harvard Medical School, Binney St. 44, Boston, 02115, Massachusetts, USA

    Craig C. Earle

  9. International Atlantic Economic Society, Peachtree Center 299, NEInternatio, Atlanta, 30303, Georgia, USA

    Katherine S. Virgo

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Humana Press

About this chapter

Cite this chapter

Sonoda, K., Kobayashi, H., Wake, N. (2013). Cervical Carcinoma Surveillance Counterpoint: Japan. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_65

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-969-7_65

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-968-0

  • Online ISBN: 978-1-60327-969-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation